Skip to content

International Consortium for Multimodality Phenotyping in Adults with Non-compaction

International Consortium for Multimodality Phenotyping in Adults with Non-compaction - NONCOMPACT

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON57174
Enrollment
120
Registered
2021-11-05
Start date
2021-05-11
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

NCCM Non-compaction cardiomyopathy

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • >=18 years old • Hypertrabeculation of the left ventricle fulfilling the echo-based Jenni criteria of NCCM • Cardiac MRI examination performed or planned for clinical purposes

Exclusion criteria

Exclusion criteria: Exclusion criteria to the study (Aim 1): • Complex congenital disease, neuromuscular disorders or isolated RV non-compaction • Inability to provide informed consent • Contra-indications to MRI Exclusion criteria to the cardiac CT exam (Aim 2): • Age 40 kg/m2 • Pregnancy (or cannot be ruled out) • Known iodine contrast medium allergy • Kidney dysfunction: eGFR

Design outcomes

Primary

MeasureTime frame
We hypothesize integrated analysis of clinical, genetic and imaging variables will improve outcome prediction in patients with NCCM. At 5 centers, 600 patients with suspected NCCM by joint adjudication will be comprehensively phenotyped and followed for up to 3 years. Independent core labs will perform comprehensive structural and functional evaluation of clinical echo and MRI exams. Adverse events are adjudicated by an independent event committee. Machine-learning techniques for complex multi-parameter predictions will be applied to develop predictive models for arrhythmic events, thromboembolic events and composite outcomes. Performance will be compared to currently used risk models and guideline-based criteria for ICD implantation and anticoagulation.

Secondary

MeasureTime frame
We hypothesize that high-resolution cardiac CT can discover structural differences between pathological non-compaction and benign hyper-trabeculation, independent of quantity. From the original cohort (Aim 1), 300 adult patients with suspected NCCM will undergo cardiac CT and advanced computational analytics including hypothesis-based features (thrombogenic cavities), measures of trabecular density and complexity, as well as hypothesis-free image interpretations of the non-compacted myocardium using artificial intelligence (radiomics), as demonstrated in our preliminary studies. Interactions between structure and function will be investigated using regional co-registration of CT and echo/MRI data. We will determine the incremental predictive value of the structural CT features to the models from the primary outcome.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)